Morishita Jintan Co., Ltd.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Dec 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 16, 2026The maintenance fee for Method for inhibition of blood phosphorus level elevation (US 9,056,122) comes due Dec 16, 2026. Unpaid by Jun 16, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,842,384 | Heat resistant capsule and process for producing the same In force · USPTO record | In force | USPTO record | |
| US 9,056,122 | Method for inhibition of blood phosphorus level elevation In force · USPTO record | In force | USPTO record | |
| US 8,741,364 | Method of improving fat metabolism In force · USPTO record | In force | USPTO record | |
| US 8,354,113 | Gene expressing a bifidobacterium surface-presented fusion protein In force · USPTO record | In force | USPTO record | |
| US 9,510,609 | Seamless capsule and manufacturing method therefor In force · USPTO record | In force | USPTO record | |
| US 8,747,893 | Capsule which disintegrates specifically in the large intestine In force · USPTO record | In force | USPTO record | |
| US 9,669,063 | Composition for prevention, amelioration or treatment of metabolic syndrome In force · USPTO record | In force | USPTO record | |
| US 12,302,935 | Three-layered capsule constructed with non-hydrogenated oil and production thereof In force · USPTO record | In force | USPTO record | |
| US 12,434,215 | Microcapsule Production Method In force · High confidence | In force | High confidence | |
| US 12,514,824 | Delayed Disintegration-Type Capsule and Method for Producing Same In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 10: 1 patent in force now held by others · 7 lapsed for an unpaid fee · 16 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 3 abandoned · 11 no status recorded